Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
08/05/2025
International Monetary Fund: The Executive Board meeting on Pakistan's funding review is scheduled to take place on May 9th.
Latest
1 m ago
Feishu became one of the first office applications to complete adaptation for HarmonyOS computers, completing the basic adaptation in one week.
3 m ago
It is rumored online that China Petroleum encourages employees to lose weight and recommends the use of Mint Health. Employees who successfully lose weight will also receive rewards.
4 m ago
Specialized and innovative products export reference catalog for new enterprises to be launched at the Beijing International Technology Expo.
5 m ago
Guggenheim maintains its rating on New York Times (NYT.US) from Neutral to Neutral, with a target price adjustment from $52.00 to $53.00.
6 m ago
Oppenheimer: Maintaining a rating of Outperform for Revolution Medicines (RVMD.US), adjusting from Outperform to Outperform rating in the market, with a target price adjusted from $70.00 to $75.00.
See all latest